Hikma Pharmaceuticals
HIK.L
#2422
Rank
NZ$10.25 B
Marketcap
$45.26
Share price
-0.20%
Change (1 day)
16.30%
Change (1 year)

EPS for Hikma Pharmaceuticals (HIK.L)

EPS in 2019 (TTM): N/A

In 2022 the company made an earnings per share (EPS) of $1.46 a decrease over its 2021 EPS that were of $3.17.

EPS history for Hikma Pharmaceuticals from 2002 to 2019

Annual EPS

Year EPS Change
2022$1.46-53.98%
2021$3.17-0.16%
2020$3.18-9.06%
2019$3.4971.62%
2018$2.04-133.3%
2017-$6.11-628.27%
2016$1.16-47.47%
2015$2.20-9.83%
2014$2.4430.48%
2013$1.87110.57%
2012$0.8923.73%
2011$0.72-19.65%
2010$0.8925.67%
2009$0.7134.54%
2008$0.53-17.84%
2007$0.6413.5%
2006$0.578.67%
2005$0.52-98.86%
2004$45.7524711.32%
2003$0.1868.25%
2002$0.11